Announcements Trials
Browse Landscape

Phase

Phase 2/3 6Phase NA 2Phase EARLY_PHASE1 2Phase 2 2Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Hematologic Neoplasms 31Lymphoma, Non-Hodgkin 24Leukemia 22Leukemia, Lymphocytic, Chronic, B-Cell 16Myelodysplastic Syndromes 15Multiple Myeloma 13Recurrence 10Lymphoma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, B-Cell 9Neoplasms 8Lymphoma, Mantle-Cell 7Burkitt Lymphoma 7Lymphoma, Follicular 6Leukemia, Plasma Cell 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia, B-Cell 6Hodgkin Disease 6Primary Myelofibrosis 5Lymphoma, T-Cell, Peripheral 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myeloid 5Hematologic Diseases 5Waldenstrom Macroglobulinemia 4Myeloproliferative Disorders 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Large Granular Lymphocytic 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasms by Site × Other hematologic neoplasm × Clear all
NCT05895994 2026-02-03

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase EARLY_PHASE1 Completed
2 enrolled
Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Neoplasms by Site, Hematologic Neoplasms

NCT05716113 2024-11-21

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Zhejiang University

Phase EARLY_PHASE1 Completed
20 enrolled
Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Neoplasms by Site, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡